Investigators presented numerous studies into new and developing therapies for diabetic macular edema and age-related macular degeneration that were aimed at reducing the treatment burden.

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...

Rensselaer researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.

If your vision is blurry or fuzzy, or if you notice that straight lines appear curved or wavy, you may have age-related ...

As people live longer than ever before, the incidence of aging-related, chronic diseases is on the rise, severely impacting ...

Rensselaer Polytechnic Institute's Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of ...

Earlier this year, EyePoint Pharmaceuticals’ drug-device combo Duravyu missed the mark in a non-proliferative diabetic ...

EyePoint Pharmaceuticals' shares rise as interim Phase 2 VERONA trial data shows Duravyu improves visual acuity and anatomy ...

“These are devastating diseases with limited treatment options,” said Curt Breneman, Ph.D., dean of Rensselaer’s School of ...

Patients with wet age-related macular degeneration receiving CLS-AX achieved stable visual acuity, and retinal thickness for ...

CBNS, such as turmeric, are natural anti-inflammatory and antioxidant agents that may confer benefits against AMD.

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...